NURALOGIX
DEAD

Serial Number

88849008

Owner

NURALOGIX CORPORATION

Attorney

Jorie L. Stroup

First Use Date

Feb 2, 2020

Filing Date

Mar 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NURALOGIX Trademark

Serial Number: 88849008

NURALOGIX is a trademark filed by NURALOGIX CORPORATION on March 26, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

NURALOGIX CORPORATION (26 trademarks)

10 King Street East Suite 200
Toronto, Ontario M5C1C3 , CA

Entity Type: 03

Trademark Details

Filing Date

March 26, 2020

Registration Date

Not Registered

First Use Anywhere

February 2, 2020

First Use in Commerce

February 2, 2020

Goods & Services

Downloadable computer software for use in providing healthcare information; downloadable computer software for providing medical information; downloadable computer software for health assessment; downloadable computer software for medical information, namely, reporting and interpreting health care data; downloadable computer software for use in measurement of biometric data; downloadable computer software for determining human health data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; downloadable computer software for use in contactless health data determination; downloadable computer software for use in predicting health risks; downloadable computer software for use in analyzing hemoglobin concentration; downloadable computer software for use in accessing and reviewing health data; downloadable computer software for use in detecting health abnormalities; downloadable applications for handheld computers, wearable computers, laptop computers, desktop computers, and mobile phones for physiological signal measurement; downloadable computer software for determining human health data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; downloadable computer software for providing health self-assessment

Providing medical information; providing healthcare information; medical screening services; health assessment services; medical diagnostic testing, monitoring and reporting services; medical information services, namely, reporting and interpreting health care results; provision of medical information related to blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; providing healthcare information from image analysis; electronic processing of health care information; providing information in the field of healthcare

Devices for measuring biometric data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; devices for non-invasive determination of biometric data; devices for analyzing hemoglobin concentration; devices for detecting health abnormalities

Software as a service (SAAS) services featuring software for use in providing healthcare information; Software as a service (SAAS) services featuring software for providing medical information; Software as a service (SAAS) services featuring software for health assessment; Software as a service (SAAS) services featuring software for medical information, namely, reporting and interpreting health care data; Software as a service (SAAS) services featuring software for use in measurement of biometric data; Software as a service (SAAS) services featuring software for determining human health data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; Software as a service (SAAS) services featuring software for use in contactless health data determination; Software as a service (SAAS) services featuring software for use in predicting health risks; Software as a service (SAAS) services featuring software for use in analyzing hemoglobin concentration; Software as a service (SAAS) services featuring software for use in accessing and reviewing health data; Software as a service (SAAS) services featuring software for use in detecting health abnormalities; Software as a service (SAAS) services featuring software for determining human health data, namely, blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; Software as a service (SAAS) services featuring software for providing health self-assessment

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 15, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 15, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 26, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2024 TROA
NOTICE OF REVIVAL - E-MAILED
Jan 9, 2024 NREV
NOTICE OF REVIVAL - E-MAILED
Jan 9, 2024 NREV
PETITION TO REVIVE-GRANTED
Jan 9, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 9, 2024 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 2, 2024 MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 30, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 30, 2023 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 12, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 12, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 12, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 12, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 28, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 28, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jan 28, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2023 CRFA
ASSIGNED TO LIE
Jan 26, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 19, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 20, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 20, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 20, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 23, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 19, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 19, 2022 GNSL
SUSPENSION LETTER WRITTEN
Feb 19, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2022 CRFA
ASSIGNED TO LIE
Jan 10, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 5, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 16, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 16, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 16, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 8, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 8, 2020 GNSL
SUSPENSION LETTER WRITTEN
Dec 8, 2020 CNSL
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 4, 2020 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 4, 2020 PARI
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 17, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 17, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 17, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2020 NWOS
NEW APPLICATION ENTERED
Mar 30, 2020 NWAP